Ebola

This Week in PNAS

In PNAS this week: population structure in Helicoverpa, AMP-activated protein kinase levels in nicotine-exposed mice, and more.

The researchers found that the expression of certain genes was better at helping them predict when Ebola would develop than indications of infection like fever.

The Fraunhofer USA team will partner with a Fraunhofer Society institute in Germany in order to reduce the cost for its patented microchip that detects viruses including Ebola.

This Week in PLOS

In PLOS this week: approach to diagnose hemorrhagic fevers, recessive disease mutations in mixed-breed dogs, and more.

The researchers found multiple enzymes that indicate causes of dysregulated adaptive immunity and tissue damage in fatal Ebola virus disease.

The German company said the open-access platform, called Pharos V8, can provide real-time PCR results in 10 minutes.   

An OpenArray panel designed to simultaneously test for 17 viruses and 13 bacteria and protozoa was able to detect pathogens from human blood donor samples with an accuracy of about 95 percent.

Presenters at ASM have used next-generation sequencing to examine Ebola, Zika, and respiratory virus infection and transmission.

The tool has been applied to determine the pathogenic cause of hemorrhagic fever, and is powering a new test for respiratory disease pathogens.

This Week in Nature

In Nature this week: reverse genetics used to gauge phenotypes of loss-of-function mutations, and more.

Pages

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.